Ex-Biotech Exec Ordered To Pay $45K Over Fraud Allegations
A Maryland federal judge on Friday ordered a former chief financial officer of biotech company Osiris, Therapeutics Inc. who was accused by the U.S. Securities and Exchange Commission of securities fraud,...To view the full article, register now.
Already a subscriber? Click here to view full article